Literature DB >> 17058151

Usefulness of fully automated constant ROI analysis software for the brain: 3DSRT and FineSRT.

Ryo Takeuchi1, Tami Sengoku, Kaname Matsumura.   

Abstract

The positioning or selection of a region of interest (ROI) is an essential step for the quantification of brain images. However, so long as the ROIs were manually selected, results obtained fluctuated considerably with subtle changes in their positioning. To perform an ROI analysis of the brain with improved objectivity and excellent reproducibility, we recently established fully automated ROI-based analysis software for the brain, the so-called 3DSRT and the FineSRT. 3DSRT performed by consecutive analyzing process as follows: (1) anatomical standardization using the SPM99 algorithm; (2) analysis using constant 318 ROIs divided into 12 groups (segments) on each hemisphere; (3) calculation of the area-weighted average for each of the respective 24 segments; (4) display of the results followed by the saving of respective values of the 636 ROIs (both hemispheres). The processes of the FineSRT were fundamentally similar to that of 3DSRT, but on FineSRT more precise constant 1394 ROIs (both hemispheres) corresponding to the respective cerebral convolutions were used. Our programs have been useful for objective estimation of cerebrovascular reserve, especially for follow-up studies of an infant with moyamoya disease, because we could compare the results without consideration of the patient's growth during the follow-up period.

Entities:  

Mesh:

Year:  2006        PMID: 17058151     DOI: 10.1007/s11604-006-0054-x

Source DB:  PubMed          Journal:  Radiat Med        ISSN: 0288-2043


  11 in total

1.  Detecting bilateral abnormalities with voxel-based morphometry.

Authors:  C H Salmond; J Ashburner; F Vargha-Khadem; D G Gadian; K J Friston
Journal:  Hum Brain Mapp       Date:  2000-11       Impact factor: 5.038

2.  Fully automated quantification of regional cerebral blood flow with three-dimensional stereotaxic region of interest template: validation using magnetic resonance imaging--technical note.

Authors:  Ryo Takeuchi; Yoshiharu Yonekura; Shigenori Katayama Naoya Takeda; Katsuzo Fujita; Junji Konishi
Journal:  Neurol Med Chir (Tokyo)       Date:  2003-03       Impact factor: 1.742

3.  Comparing functional (PET) images: the assessment of significant change.

Authors:  K J Friston; C D Frith; P F Liddle; R S Frackowiak
Journal:  J Cereb Blood Flow Metab       Date:  1991-07       Impact factor: 6.200

4.  Noninvasive quantitative measurements of regional cerebral blood flow using technetium-99m-L,L-ECD SPECT activated with acetazolamide: quantification analysis by equal-volume-split 99mTc-ECD consecutive SPECT method.

Authors:  R Takeuchi; H Matsuda; Y Yonekura; H Sakahara; J Konishi
Journal:  J Cereb Blood Flow Metab       Date:  1997-10       Impact factor: 6.200

5.  A quantitative approach to technetium-99m hexamethylpropylene amine oxime.

Authors:  H Matsuda; S Tsuji; N Shuke; H Sumiya; N Tonami; K Hisada
Journal:  Eur J Nucl Med       Date:  1992

6.  The retention of [99mTc]-d,l-HM-PAO in the human brain after intracarotid bolus injection: a kinetic analysis.

Authors:  N A Lassen; A R Andersen; L Friberg; O B Paulson
Journal:  J Cereb Blood Flow Metab       Date:  1988-12       Impact factor: 6.200

7.  Resting and acetazolamide-challenged technetium-99m-ECD SPECT in transient global amnesia.

Authors:  R Takeuchi; Y Yonekura; H Matsuda; Y Nishimura; H Tanaka; H Ohta; H Sakahara; J Konishi
Journal:  J Nucl Med       Date:  1998-08       Impact factor: 10.057

8.  Cerebral blood flow SPET in transient global amnesia with automated ROI analysis by 3DSRT.

Authors:  Ryo Takeuchi; Hiroshi Matsuda; Katsunori Yoshioka; Yoshiharu Yonekura
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-01-14       Impact factor: 9.236

9.  A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET.

Authors:  S Minoshima; K A Frey; R A Koeppe; N L Foster; D E Kuhl
Journal:  J Nucl Med       Date:  1995-07       Impact factor: 10.057

10.  A quantitative approach to technetium-99m ethyl cysteinate dimer: a comparison with technetium-99m hexamethylpropylene amine oxime.

Authors:  H Matsuda; A Yagishita; S Tsuji; K Hisada
Journal:  Eur J Nucl Med       Date:  1995-07
View more
  5 in total

1.  Hemichorea in a thymoma patient without anti-CRMP-5 antibody.

Authors:  Yoshiharu Nakae; Shingo Ikeda; Ryoo Yamamoto; Fumiaki Tanaka; Ken Johkura
Journal:  Neurol Sci       Date:  2014-01-11       Impact factor: 3.307

2.  Apolipoprotein E4 frequencies in a Japanese population with Alzheimer's disease and dementia with Lewy bodies.

Authors:  Seiju Kobayashi; Masaru Tateno; Tae Woo Park; Kumiko Utsumi; Hitoshi Sohma; Yoichi M Ito; Yasuo Kokai; Toshikazu Saito
Journal:  PLoS One       Date:  2011-04-28       Impact factor: 3.240

3.  Optimal ROI setting on the anatomically normalized I-123 FP-CIT images using high-resolution SPECT.

Authors:  Masanari Nonokuma; Yasuo Kuwabara; Kosuke Hida; Tomonobu Tani; Koichi Takano; Kengo Yoshimitsu
Journal:  Ann Nucl Med       Date:  2016-07-20       Impact factor: 2.668

4.  Neuropsychological Evaluation and Cerebral Blood Flow Effects of Apolipoprotein E4 in Alzheimer's Disease Patients after One Year of Treatment: An Exploratory Study.

Authors:  Azusa Suwa; Keiichiro Nishida; Keita Utsunomiya; Shinpei Nonen; Masafumi Yoshimura; Yoshiteru Takekita; Masataka Wakeno; Aran Tajika; Maki Yoshino; Yosuke Koshikawa; Masaki Kato; Toshihiko Kinoshita
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2015-10-22

5.  Prediction of Cognitive Decline from White Matter Hyperintensity and Single-Photon Emission Computed Tomography in Alzheimer's Disease.

Authors:  Ken-Ichi Tabei; Hirotaka Kida; Tetsuo Hosoya; Masayuki Satoh; Hidekazu Tomimoto
Journal:  Front Neurol       Date:  2017-09-04       Impact factor: 4.003

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.